Science Explorer Back to mapMap
Discussion
Topic · Endocrinology, Diabetes and Metabolism

Diabetes Treatment and Management

Diabetes Treatment and Management is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 46k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management of diabetes mellitus, with a particular emphasis on cardiovascular outcomes, glucose control, and the use of incretin hormones, SGLT2 inhibitors, and dipeptidyl peptidase-4 inhibitors. It also covers topics such as heart failure, glycemic control, insulin therapy, and clinical guidelines for the treatment of type 2 diabetes.

  • Type 2 Diabetes
  • Cardiovascular Outcomes
  • Glucose Control
  • Incretin Hormones
  • SGLT2 Inhibitors
  • Dipeptidyl Peptidase-4 Inhibitors
  • Heart Failure
  • Glycemic Control
  • Insulin Therapy
  • Clinical Guidelines
Research works
46k
fractional, since 1950
In the world top 10%
4.6k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+40%
the tick is no change
Largest producer
United States
38% of the 10 largest, 2022-now
Diabetes Treatment and Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Diabetes Treatment and Management research?

By volume, the United States and China publish the most (3.5k and 1.7k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.5k works
  2. 2 China 1.7k works
  3. 3 India 780 works
  4. 4 United Kingdom 674 works
  5. 5 Japan 583 works
  6. 6 Italy 518 works
  7. 7 Germany 492 works
  8. 8 Canada 355 works
  9. 9 Spain 345 works
  10. 10 South Korea 328 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 38.0%China: 18.3%India: 8.4%United Kingdom: 7.2%6 others listed: 28.2%38%largest
United States3,536 · 38.0%China1,701 · 18.3%India780 · 8.4%United Kingdom674 · 7.2%6 others listed2,622 · 28.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Diabetes Treatment and Management research?

By volume in 2022-now, Harvard University publishes the most Diabetes Treatment and Management research, followed by University of Toronto and University of Copenhagen.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 166 works
  2. 2 University of TorontoCanada 91 works
  3. 3 University of CopenhagenDenmark 84 works
  4. 4 Mayo ClinicUnited States 82 works
  5. 5 Novo Nordisk (Denmark)Denmark 77 works
  6. 6 Johns Hopkins UniversityUnited States 62 works
  7. 7 Peking UniversityChina 56 works
  8. 8 United States Department of Veterans AffairsUnited States 54 works
  9. 9 Eli Lilly (United States)United States 52 works
  10. 10 InsermFrance 49 works

Who are the leading researchers in Diabetes Treatment and Management?

The most-cited researchers publishing on Diabetes Treatment and Management include David Moher, Christopher J L Murray and Eric S. Lander.

  1. 1 David Moher Canada 898k citations
  2. 2 Christopher J L Murray United States 583k citations
  3. 3 Eric S. Lander United States 524k citations
  4. 4 Simon Iain Hay United States 452k citations
  5. 5 Theo Vos United States 439k citations
  6. 6 George Davey Smith United Kingdom 435k citations
  7. 7 Mark J. Daly United States 403k citations
  8. 8 Stacey L. Gabriel United States 402k citations
  9. 9 Julian P. T. Higgins United Kingdom 390k citations
  10. 10 John J.V. McMurray United Kingdom 349k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Diabetes Treatment and Management?

The most cited paper in Diabetes Treatment and Management is "Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man" (David Richard Matthews, J P Hosker, A. Rudenski et al., 1985), with 31,761 citations. Next come "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation" (15,336) and "International Diabetes Federation 2017" (13,571).

Most cited papers
#PaperReleasedCitations
1 Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David Richard Matthews, J P Hosker, A. Rudenski et al. · Diabetologia Open access Jul 1985 31,761
2 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation K. G. M. M. Alberti, Paul Zimmet, WHO Consultation · Diabetic Medicine Jul 1998 15,336
3 International Diabetes Federation 2017 Ann M. Carracher, Payal H. Marathe, Kelly L. Close · Journal of Diabetes 18 Jan 2018 13,571
4 Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine Open access 17 Sep 2015 12,282
5 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study IRENE M. STRATTON · BMJ Open access 12 Aug 2000 9,131
All 100 most cited papers, with filters and sorting

Where is Diabetes Treatment and Management research done?

The largest centres of Diabetes Treatment and Management research in 2022-now are Beijing (China), Seoul (South Korea), London (United Kingdom) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Charlottenlund.

Largest cities, 2022-now

  1. 1 BeijingChina 254 works
  2. 2 SeoulSouth Korea 181 works
  3. 3 LondonUnited Kingdom 180 works
  4. 4 BostonUnited States 163 works
  5. 5 CopenhagenDenmark 157 works
  6. 6 TokyoJapan 149 works
  7. 7 New YorkUnited States 141 works
  8. 8 ShanghaiChina 133 works
  9. 9 TorontoCanada 132 works
  10. 10 GuangzhouChina 102 works

Where it is the local speciality

  1. CharlottenlundDK · 26.5 works67×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Diabetes Treatment and Management than the world average.

See Diabetes Treatment and Management on the map

Where is the best place to study Diabetes Treatment and Management?

Among universities, judged by research, Harvard University, University of Toronto and Case Western Reserve University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 19.9%fractional works in this field (log) →share of work in the world top 10% →Case Western Reserve…University of TorontoHarvard UniversityUniversity of Copenh…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 82.518.2%4.4×166 +44.7%
2University of TorontoCanada 78.321.6%3.8×92 +2.4%
3Case Western Reserve UniversityUnited States 72.623.5%6.1×44 +197.3%
4University of CopenhagenDenmark 68.515.2%7.5×84 -13.4%
5Johns Hopkins UniversityUnited States 68.416.0%3.4×62 +45.5%
6University of GothenburgSweden 67.022.7%3.5×20 +44.0%
7University of LeicesterUnited Kingdom 66.126.9%8.1×26 -11.2%
8University of GroningenNetherlands 65.117.7%4.5×37 +7.5%
9Imperial College LondonUnited Kingdom 65.118.2%2.8×33 +25.6%
10McGill UniversityCanada 65.019.0%2.8×33 +75.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Diabetes Treatment and Management, country by country

Is Diabetes Treatment and Management research growing?

Output in 2022-2025 was 40% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Diabetes Treatment and Management.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Diabetes Treatment and Management as a percentage of every work published that year, 0.055% in 2024.

still counting0.025%0.050%0.075%Diabetes Treatment and Management0.064% in 202519801990200020102020

Fractional works of Diabetes Treatment and Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Diabetes Treatment and Management9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Diabetes Treatment and Management. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.